These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1446 related articles for article (PubMed ID: 24874276)

  • 1. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
    Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
    Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
    Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
    Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphenol A Increases the Migration and Invasion of Triple-Negative Breast Cancer Cells via Oestrogen-related Receptor Gamma.
    Zhang XL; Liu N; Weng SF; Wang HS
    Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):389-95. PubMed ID: 27038254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
    Girgert R; Emons G; Gründker C
    BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
    He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
    Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer.
    Yin J; Tu G; Peng M; Zeng H; Wan X; Qiao Y; Qin Y; Liu M; Luo H
    FASEB J; 2020 Mar; 34(3):4557-4572. PubMed ID: 32030797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX; Yang XH; Li YN; Guo L
    Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
    Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
    Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
    Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
    Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
    Tao S; He H; Chen Q; Yue W
    Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.